Cross-sectional epidemiology of hepatitis C virus detection and treatment in HIV-infected patients

European Journal of Internal Medicine

Volumn 22, Issue 1, 2011, Pages 66-72

  Ena, Javier ^a   Ruiz De Apodaca, Rosa F ^a   Pasquau, Francisco ^a   Amador, Concepción ^a   Benito, Concepción ^a  

^a HOSPITAL MARINA BAIXA   (Spain)

Author keywords

Cross sectional studies; Hepatitis C virus; Human immunodeficiency virus

Indexed keywords

PEGINTERFERON ALPHA2A PLUS RIBAVIRIN; VIRUS RNA;

ADULT; ARTICLE; DRUG CONTRAINDICATION; EDUCATIONAL STATUS; FEMALE; GENOTYPE; HEPATITIS C; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MAJOR CLINICAL STUDY; MALE; MARRIAGE; MIXED INFECTION; VIRUS DETECTION; VIRUS LOAD;

ADULT; ANTIVIRAL AGENTS; CROSS-SECTIONAL STUDIES; DRUG THERAPY, COMBINATION; EDUCATIONAL STATUS; FEMALE; HEPACIVIRUS; HEPATITIS C; HIV INFECTIONS; HUMANS; INTERFERON ALFA-2A; INTERFERON ALFA-2B; MALE; MEDICAL RECORDS; MIDDLE AGED; POLYETHYLENE GLYCOLS; RIBAVIRIN; RISK ASSESSMENT; RISK FACTORS; SPAIN; STATISTICS, NONPARAMETRIC;

EID: 78751574185     PISSN: 09536205     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejim.2010.08.006     Document Type: Article

References (29)

1. S. Pérez Cachafeiro, J. Del Amo, J.A. Iribarren, M. Salavert Lleti, F. Gutiérrez, and A. Moreno Decrease in serial prevalence of coinfection with hepatitis C virus among HIV-infected patients in Spain, 1997-2006 Clin Infect Dis 48 2009 1467 1470
2. N. Qurishi, C. Kreuzberg, G. Lüchters, W. Effenberger, B. Kupfer, and T. Sauerbruch Effect of antiretroviral therapy on liver-related mortality in patients with HIV and hepatitis C virus coinfection Lancet 362 2003 1708 1713
3. J. Macías, J. Berenguer, M.A. Japón, J.A. Girón, A. Rivero, and L.F. López-Cortés Fast fibrosis progression between repeated liver biopsies in patients coinfected with human immunodeficiency virus/hepatitis C virus Hepatology 50 2009 1056 1063
4. J.K. Rockstroh, S. Bhagani, Y. Benhamou, R. Bruno, S. Mauss, and L. Peters European AIDS Clinical Society (EACS) guidelines for the clinical management and treatment of chronic hepatitis B and C coinfection in HIV-infected adults HIV Med 9 2008 82 88
5. J. Berenguer, J. Alvarez-Pellicer, P.M. Martín, J. López-Aldeguer, M.A. Von-Wichmann, and C. Quereda Sustained virological response to interferon plus ribavirin reduces liver-related complications and mortality in patients coinfected with human immunodeficiency virus and hepatitis C virus Hepatology 50 2009 407 413
6. C. Tural, J. Tor, A. Sanvisens, N. Pérez-Alvarez, E. Martínez, and I. Ojanguren Accuracy of simple biochemical tests in identifying liver fibrosis in patients co-infected with human immunodeficiency virus and hepatitis C virus Clin Gastroenterol Hepatol 7 2009 339 345
7. S.H. Mehta, G.M. Lucas, L.B. Mirel, M. Torbenson, Y. Higgins, and R.D. Moore Limited effectiveness of antiviral treatment for hepatitis C in an urban HIV clinic AIDS 20 2006 2361 2369
8. L.E. Taylor Delivering care to injection drug users coinfected with HIV and hepatitis C virus Clin Infect Dis 40 Suppl 5 2005 S355 S361
9. L.I. Backus, D.B. Boothroyd, B.R. Phillips, and L.A. Mole Pretreatment assessment and predictors of hepatitis C virus treatment in US veterans coinfected with HIV and hepatitis C virus J Viral Hepat 13 2006 799 810
10. I. Maida, V. Soriano, B. Ramos, P. Rios, J. Gonzalez-Lahoz, and M. Nuñez Characteristics and prospects for hepatitis C therapy o fan HIV-HCV coinfected population followed at a reference HIV center HIV Clin Trials 6 2005 329 336
11. L. Martin-Carbonero, M. Nuñez, A. Mariño, F. Alcocer, L. Bonet, and J. Garcia-Samaniego Indetectable hepatitis C virus RNA at week 4 as predictor of sustained virological response in HIV patients with chronic hepatitis C AIDS 22 2008 15 21
12. L. Valerio, Y. Yazdanpanah, I. Poizot-Martin, E. Rosenthal, C. Marimoutou, and J.A. Gastaut Baseline CD4 cell count and outcome of pegylated interferon plus ribavirin therapy in HIV/hepatitis C virus-coinfected patients J Acquir Immune Defic Syndr 47 2008 50 55
13. J.A. Pineda, J.A. Mira, L. Gil I de, B. Valera-Bestard, A. Rivero, and D. Merino Influence of concomitant antiretroviral therapy on the rate of sustained virological response to pegylated interferon plus ribavirin in hepatitisC virus/HIV-coinfected patients J Antimicrob Chemother 60 2007 1347 1354
14. R.T. Chung, J. Andersen, P. Volberding, G.K. Robbins, T. Liu, and K.E. Sherman Peginterferon Alfa-2a plus ribavirin versus interferon alfa-2a plus ribavirin for chronic hepatitis C in HIV-coinfected persons N Engl J Med 351 2004 451 459
15. F.J. Torriani, M. Rodriguez-Torres, J.K. Rockstroh, E. Lissen, J. Gonzalez-García, and A. Lazzarin Peginterferon Alfa-2a plus ribavirin for chronic hepatitis C virus infection in HIV-infected patients N Engl J Med 351 2004 438 450
16. C.M. Behler, E. Vittinghoff, F. Linn, R.T. Chung, M.G. Peters, and G.K. Robbins Hematologic toxicity associated with interferon-based hepatitis C therapy in HIV type 1-coinfected subjects Clin Infect Dis 44 2007 1375 1383
17. D. Nunes, R. Saitz, H. Libman, D.M. Cheng, J. Vidaver, and J.H. Samet Barriers to treatment of hepatitis C in HIV/HCV-coinfected adults with alcohol problems Alcohol Clin Exp Res 30 2006 1520 1526 (Pubitemid 44272741)
18. M. McLaren, G. Garber, and C. Cooper Barriers to hepatitis C virus treatment in a Canadian HIV-hepatitis C virus coinfection tertiary care clinic Can J Gastroenterol 22 2008 133 137
19. P. Cacoub, E. Rosenthal, P. Halfon, D. Sene, C. Perronne, and S. Pol Treatment of hepatitis C virus and human immunodeficiency virus coinfection: from large trials to real life J Viral Hepat 13 2006 678 682
20. M.S. Huckans, A.D. Blackwell, T.A. Harms, D.W. Indest, and P. Hauser Integrated hepatitis C virus treatment: addressing comorbid substance use disorders and HIV infection AIDS 19 Suppl 3 2005 S106 S115
21. B.R. Edlin, T.F. Kresina, D.B. Raymond, M.R. Carden, M.N. Gourevitch, and J.D. Rich Overcoming barriers to prevention, care, and treatment of hepatitis C in illicit drug users Clin Infect Dis 40 Suppl 5 2005 S276 S285
22. H. Scheft, and D.C. Fontenette Psychiatric barriers to readiness for treatment for hepatitis C Virus (HCV) infection among injection drug users: clinical experience of an addiction psychiatrist in the HIV-HCV coinfection clinic of a public health hospital Clin Infect Dis 40 Suppl 5 2005 S292 S296
23. V. Gordillo, J. del Amo, V. Soriano, and J. González-Lahoz Sociodemographic and psychological variables influencing adherence to antiretroviral therapy AIDS 13 1999 1763 1769
24. M.R. DiMatteo Social support and patient adherence to medical treatment: a meta-analysis Health Psychol 23 2004 207 218
25. K.A. Clanon, J. Johannes Mueller, and M. Harank Integrating treatment for hepatitis C virus infection into an HIV clinic Clin Infect Dis 40 Suppl 5 2005 S362 S366
26. T.F. Kresina, R.D. Bruce, V.A. Cargill, and L.W. Cheever Integrating care for hepatitis C virus (HCV) and primary care for HIV for injection drug users coinfected with HIV and HCV Clin Infect Dis 41 Suppl 1 2005 S83 S88
27. L. Balfour, C. Cooper, G.A. Tasca, M. Kane, J. Kowal, and G. Garber Evaluation of health care needs and patient satisfaction among hepatitis C patients treated at a hospital-based, viral hepatitis clinic Can J Public Health 95 2004 272 277
28. J.A. Pineda, J.A. García-García, M. Aguilar-Guisado, M.J. Ríos-Villegas, J. Ruiz-Morales, and A. Rivero Clinical progression of hepatitis C virus-related chronic liver disease in human immunodeficiency virus-infected patients undergoing highly active antiretroviral therapy Hepatology 46 2007 622 630
29. Panel de expertos de Gesida y Plan Nacional sobre el Sida Recommendations from the GESIDA/Spanish AIDS Plan regarding antiretroviral treatment in adults with human immunodeficiency virus infection (update February 2009) Enferm Infecc Microbiol Clín 27 2009 222 235